Firm Heterogeneity in Biotech: Absorptive Capacity, Strategies and Local-Regional Connections

References

• Arora, A. & Gambardella, A. (1994) Evaluating technological information and utilizing it, Journal of Economic Behavior and Organization, 24(1), pp. 91–114. doi: 10.1016/0167-2681(94)90055-8
   Web of Science ®Google Scholar
• Audretsch, D. B. & Stephan, P. E. (1996) Company-scientist locational links: The case of biotechnology, The American Economic Review, 86(3), pp. 641–652.
   Web of Science ®Google Scholar
• Audretsch, D. B. & Stephan, P. E. (1999) Knowledge spillovers in biotechnology: Sources and incentives, Journal of Evolutionary Economics, 9(1), pp. 97–107. doi: 10.1007/s001910050076
   Web of Science ®Google Scholar
• Autant-Bernard, C., Mangematin, V. & Massard, N. (2006) Creation of biotech SMEs in France, Small Business Economics, 26(2), pp. 173–187. doi: 10.1007/s11187-004-3578-4
   Web of Science ®Google Scholar
• Bagchi-Sen, S. & Scully, J. (2007) Strategies and external relationships of small- and medium-sized enterprises in the U.S. agricultural biotechnology sector, Environment and Planning C, 25(6), pp. 844–860. doi: 10.1068/c0560
   Web of Science ®Google Scholar
• Bierly, P. & Chakrabarti, A. (1996) Generic knowledge strategies in the U.S. pharmaceutical industry, Strategic Management Journal, 17(Winter), pp. 123–135. doi: 10.1002/smj.4250171111
   Web of Science ®Google Scholar
• Cohen, W. M. & Levinthal, D. A. (1990) Absorptive capacity: A new perspective on learning and innovation, Administrative Science Quarterly, 35(1), pp. 128–152. doi: 10.2307/2393553
   Web of Science ®Google Scholar
• Cooke, P. (2002) Biotechnology clusters as regional, sectoral innovation systems, International Regional Science Review, 25(1), pp. 8–37. doi: 10.1177/016001760202500102
   Web of Science ®Google Scholar
• Cooke, P. (2004) The molecular biology revolution and the rise of bioscience megacentres in North America, Environment and Planning C: Government and Policy, 22(2), pp. 161–177. doi: 10.1068/c0344
   Web of Science ®Google Scholar
• Cooke, P. (2005) Rational drug design, the knowledge value chain and bioscience megacentres, Cambridge Journal of Economics, 29(3), pp. 325–341. doi: 10.1093/cje/bei045
   Web of Science ®Google Scholar
• Coombs, J. E. & Deeds, D. L. (2000) International alliances as sources of capital: Evidence from the biotechnology industry, The Journal of High Technology Management Research, 11(2), pp. 235–253. doi: 10.1016/S1047-8310(00)00031-6
   Google Scholar
• Del Canto, J. G. & Gonzalez, I. S. (1999) A resource-based analysis of the factors determining a firm's R&D activities, Research Policy, 28(8), pp. 891–905. doi: 10.1016/S0048-7333(99)00029-3
   Web of Science ®Google Scholar
• Dickson, K., Coles, A.-M. & Lawton Smith, H. (1997) Staying the course: Strategic collaboration for small high tech firms, Small Business & Enterprise Development, 4(1), pp. 13–20. doi: 10.1002/(SICI)1099-1662(199703)4:1<13::AID-SBE72>3.0.CO;2-3
   Google Scholar
• Dunning, J. H. (1997) Alliance Capitalism and Global Business (London: Routledge).
   Google Scholar
• Fabrizio, K. R. (2004) Absorptive Capacity and Innovation: Evidence from Pharmaceutical and Biotechnology Firms. Available at http://www.hbs.edu/units/tom/seminars/2004/kmarkiewicz.pdf (accessed 4 August 2008).
   Google Scholar
• Feldman, M. P. (2005) The locational dynamics of the US biotech Industry: Knowledge externalities and the anchor hypothesis, in: A. Q. Curzio & M. Fortis (Eds) Research and Technological Innovation, pp. 201–225 (Heidelberg: Physics Verlag).
   Google Scholar
• Gans, J. & Stern, S. (2003) The product market and the market for “ideas”: Commercialization strategies for technology entrepreneurs, Research Policy, 32(2), pp. 333–350. doi: 10.1016/S0048-7333(02)00103-8
   Web of Science ®Google Scholar
• George, G., Zahra, S. A., Wheatley, K. K. & Khan, R. (2001) The effects of alliance portfolio characteristics and absorptive capacity on performance—a study of biotechnology firms, Journal of High Technology Management Research, 12(2), pp. 205–226. doi: 10.1016/S1047-8310(01)00037-2
   Google Scholar
• Gittleman, M. & Kogut, B. (2003) Does good science lead to valuable knowledge? Biotechnology firms and the evolutionary logic of citation patterns, Management Science, 49(4), pp. 366–382. doi: 10.1287/mnsc.49.4.366.14420
   Web of Science ®Google Scholar
• Greis, N. P., Dibner, M. D. & Bean, A. S. (1995) External partnering as a response to innovation barriers and global competition in biotechnology, Research Policy, 24(4), pp. 609–630. doi: 10.1016/S0048-7333(94)00789-6
   Web of Science ®Google Scholar
• Kaitin, K. I. (2007) Structuring the Clinical Organization to Improve R&D Productivity, Tufts Center for the Study of Drug Development R&D Management Report, March 2(1). Boston, MA: Tufts University.
   Google Scholar
• Kenney, M. (1986) Biotechnology: The University-Industrial Complex (New Haven, CT: Yale University Press).
   Google Scholar
• Kim, C. S. & Inkpen, A. C. (2005) Cross-border R&D alliances, absorptive capacity and technology learning, Journal of International Management, 11(3), pp. 313–329. doi: 10.1016/j.intman.2005.06.002
   Google Scholar
• Kodama, F. (1995) Emerging Patterns of Innovations: Sources of Japan's Technological Edge (Boston, MA: Harvard Business School Press).
   Google Scholar
• Koza, M. P. & Lewin, A. Y. (1998) The co-evolution of strategic alliances, Organization Science, 9(2), pp. 255–264. doi: 10.1287/orsc.9.3.255
   Web of Science ®Google Scholar
• Lane, P. J. & Lubatkin, M. (1998) Relative absorptive capacity and interorganizational learning, Strategic Management Journal, 19(5), pp. 461–477. doi: 10.1002/(SICI)1097-0266(199805)19:5<461::AID-SMJ953>3.0.CO;2-L
   Web of Science ®Google Scholar
• Lawton Smith, H., Glasson, J. & Chadwick, A. (2007) Enterprising Oxford: The Oxfordshire Model (Oxford: Oxfordshire Economic Observatory).
   Google Scholar
• Lee, C.-W. (2007) Strategic alliances influences on small and medium firm performance, Journal of Business Research, 60(7), pp. 731–741. doi: 10.1016/j.jbusres.2007.02.018
   Web of Science ®Google Scholar
• Liebeskind, J. P., Oliver, A. L., Zucker, L. G. & Brewer, M. B. (1995) Social Networks, Learning and Flexibility: Sourcing Scientific Knowledge in New Biotechnology Firms, NBER Working Paper Series, No. 5320, Cambridge, MA: National Bureau of Economic Research.
   Google Scholar
• Lin, B. W., Lee, Y. & Hung, S. C. (2006) R&D intensity and commercialization orientation effects on financial performance, Journal of Business Research, 59(6), pp. 679–685. doi: 10.1016/j.jbusres.2006.01.002
   Web of Science ®Google Scholar
• Linder, J. C., Perkins, S. & Dover, P. (2004) The Drug Industry Alliances: In Search of Strategy. A research report prepared by Accenture in association with Babson Executive Education. Available at http://www.accenture.com
   Google Scholar
• Madhok, A. & Osegowitsch, T. (2000) The international biotechnology industry: Dynamic capabilities perspective, Journal of International Business Studies, 31(2), pp. 325–335. doi: 10.1057/palgrave.jibs.8490909
   Web of Science ®Google Scholar
• Mowery, D. C. & Rosenberg, N. (1989) Technology and the Pursuit of Economic Growth (Cambridge: Cambridge University Press).
   Google Scholar
• Mowery, D. C. & Rosenberg, N. (1996) Paths of Innovation: Technological Change in 20th-Century America (Cambridge: Cambridge University Press).
   Google Scholar
• Newey, L. R. & Shulman, A. D. (2004) Systemic absorptive capacity: Creating early-to-market returns through R&D alliances, R&D Management, 4(5), pp. 495–504.
   Web of Science ®Google Scholar
• Oliver, A. L. & Montgomery, K. (2000) Creating a hybrid organizational form from parental. blueprints: The emergence and evolution of knowledge firms, Human Relations, 53(1), pp. 33–56. doi: 10.1177/0018726700531003
   Web of Science ®Google Scholar
• Pisano, G. (1990) The R&D boundaries of the firm: An empirical analysis, Administrative Science Quarterly, 35(1), pp. 153–176. doi: 10.2307/2393554
   Web of Science ®Google Scholar
• Pisano, G. (1991) The governance of innovation: Vertical integration and collaborative arrangements in the biotechnology industry, Research Policy, 20(3), pp. 237–249. doi: 10.1016/0048-7333(91)90054-T
   Web of Science ®Google Scholar
• Pisano, G. (2006) Can science be a business? Lessons from biotech, Harvard Business Review, October, pp. 114–125. Available at http://sciencepolicy.colorado.edu/students/envs_5100/Pisano.pdf (accessed 11 December 2008).
   Google Scholar
• Pisano, G., Shan, W. & Teece, D. J. (1988) Joint ventures and collaboration in the biotechnology industry, in: D. Mowery (Ed.) International Collaborative Ventures in U.S. Manufacturing, pp. 183–222 (Cambridge, MA: Ballinger).
   Google Scholar
• Powell, W., Koput, K. W. & Smith-Doerr, L. (1996) Inter-organizational collaboration and the locus of innovation: Networks of learning in biotechnology, Administrative Science Quarterly, 41(1), pp. 116–145. doi: 10.2307/2393988
   Web of Science ®Google Scholar
• Powell, W., Koput, K. W., Bowie, J. I. & Smith-Doerr, L. (2002) The spatial clustering of science and capital: Accounting for biotech firm-venture capital relationships, Regional Studies, 36(3), pp. 291–305. doi: 10.1080/00343400220122089
   Web of Science ®Google Scholar
• Prevezer, M. (2001) Ingredients in the early development of the U.S. biotechnology industry, Small Business Economics, 17(1), pp. 17–29. doi: 10.1023/A:1011174421603
   Web of Science ®Google Scholar
• Prevezer, M. & Toker, S. (1996) The degree of integration in strategic alliances in biotechnology, Technology Analysis and Strategic Management, 8(1–2), pp. 117–133. doi: 10.1080/09537329608524239
   Web of Science ®Google Scholar
• Roger, M. (2002) Firm Performance and Investment in R&D and Intellectual Property. Available at http://melbourneinstitute.com/wp/wp2002n15.pdf (accessed 1 August 2008).
   Google Scholar
• Rothaermel, F. T. & Deeds, D. L. (2004) Exploration and exploitation alliances in biotechnology: A system of new product development, Strategic Management Journal, 3(3), pp. 201–221. doi: 10.1002/smj.376
   Web of Science ®Google Scholar
• Shefer, D. & Frenkel, A. (2005) R&D, firm size and innovation: An empirical analysis, Technovation, 25(1), pp. 25–32. doi: 10.1016/S0166-4972(03)00152-4
   Web of Science ®Google Scholar
• Traore, N. (2004) Canadian biotech firms’ creative capacity: On the role of absorptive capacity, relational capital, learning, and firm characteristics, International Journal of Biotechnology, 6(1), pp. 1–19. doi: 10.1504/IJBT.2004.004609
   Google Scholar
• Tsai, K. H. (2005) R&D productivity and firm size: A nonlinear examination, Technovation, 25(7), pp. 795–803. doi: 10.1016/j.technovation.2003.12.004
   Web of Science ®Google Scholar
• Van den Bosch, F., Volberda, H. & De Boer, M. (1999) Co-evolution of firm absorptive capacity and knowledge environment: Organizational forms and combinative capabilities, Organization Science, 10(5), pp. 551–568. doi: 10.1287/orsc.10.5.551
   Web of Science ®Google Scholar
• Veuglers, R. (1997) Internal R&D expenditures and external technology sourcing, Research Policy, 26(3), pp. 303–315. doi: 10.1016/S0048-7333(97)00019-X
   Web of Science ®Google Scholar
• Zucker, L. G. & Darby, M. R. (1996) Star scientists and institutional transformation: Patterns of invention and innovation in the formation of the biotechnology industry, Proceedings of the National Academy of Sciences USA, 93(23), pp. 12709–12716. doi: 10.1073/pnas.93.23.12709
   PubMed Web of Science ®Google Scholar